FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048446675> ?p ?o ?g. }

• W2048446675 abstract "Structured treatment interruptions (STIs) have been postulated to improve virologic control in primary HIV infection (PHI) by stimulating HIV-specific T-lymphocyte immunity. The addition of hydroxyurea (HU) may reduce viral production from activated CD4 cells.Patients with PHI received a standardized antiretroviral (ARV) regimen consisting of indinavir 800 mg twice daily (BID), ritonavir 100 mg BID, didanosine 400 mg (QD), and either stavudine 40 mg BID or lamivudine 150 mg BID, for up to 12 months and were randomized to HU 500 mg BID or not. If viral suppression (<50 copies/mL) was achieved, up to 3 STIs were undertaken. Two ARV cycles were allowed after each interruption if virologic rebound to more than 5000 RNA copies/mL occurred. Treatment success was defined as maintaining viral loads below 5000 copies/mL for 6 months after ARV interruption.Sixty-eight male homosexual patients were randomized: 35 to ARV + HU and 33 to ARV-alone. Median baseline HIV RNA was 5.73 log10 copies/mL, and median CD4 T-lymphocyte count was 517 cells/microL. Treatment success was not significantly different between those receiving and not receiving HU, with 9 (26%) and 9 (27%), respectively, maintaining viral load at less than 5000 copies/mL in each group (P = 0.88). Virologic control was achieved by 11 (19%) of 59 after 1 STI, 1 (2%) of 41 after 2 STIs, and 6 (17%) of 36 after the third STI. Serious adverse events were recorded for 9 (26%) of 35 of patients using HU and 3 (9%) of 33 in the ARV-only group (P = 0.28). CD4 cell increases were significantly blunted for the HU group compared to the ARV-alone group after the initial treatment phase (+101 cells vs. +196 cells, respectively, P = 0.006).Hydroxyurea was not found to be beneficial when used in association with STIs in patients during PHI." @default.
• W2048446675 created "2016-06-24" @default.
• W2048446675 creator A5018068497 @default.
• W2048446675 creator A5019902771 @default.
• W2048446675 creator A5031995978 @default.
• W2048446675 creator A5041046421 @default.
• W2048446675 creator A5063673979 @default.
• W2048446675 creator A5066678441 @default.
• W2048446675 creator A5068183703 @default.
• W2048446675 creator A5068421356 @default.
• W2048446675 creator A5069833123 @default.
• W2048446675 creator A5074256223 @default.
• W2048446675 creator A5079591035 @default.
• W2048446675 creator A5079993549 @default.
• W2048446675 creator A5085944444 @default.
• W2048446675 creator A5088309165 @default.
• W2048446675 date "2006-06-01" @default.
• W2048446675 modified "2023-09-27" @default.
• W2048446675 title "The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection" @default.
• W2048446675 cites W1528842764 @default.
• W2048446675 cites W1815763197 @default.
• W2048446675 cites W1964016451 @default.
• W2048446675 cites W1969133711 @default.
• W2048446675 cites W1969303851 @default.
• W2048446675 cites W1970394208 @default.
• W2048446675 cites W1973712699 @default.
• W2048446675 cites W1974212577 @default.
• W2048446675 cites W1976292095 @default.
• W2048446675 cites W1976828027 @default.
• W2048446675 cites W1978406880 @default.
• W2048446675 cites W1979871674 @default.
• W2048446675 cites W1994966130 @default.
• W2048446675 cites W2016156911 @default.
• W2048446675 cites W2020096299 @default.
• W2048446675 cites W2025481552 @default.
• W2048446675 cites W2026615262 @default.
• W2048446675 cites W2030844138 @default.
• W2048446675 cites W2034659049 @default.
• W2048446675 cites W2034760164 @default.
• W2048446675 cites W2035215938 @default.
• W2048446675 cites W2037343680 @default.
• W2048446675 cites W2040458628 @default.
• W2048446675 cites W2051204107 @default.
• W2048446675 cites W2058018720 @default.
• W2048446675 cites W2059761504 @default.
• W2048446675 cites W2072010067 @default.
• W2048446675 cites W2079905097 @default.
• W2048446675 cites W2081751774 @default.
• W2048446675 cites W2083510193 @default.
• W2048446675 cites W2094583956 @default.
• W2048446675 cites W2106336618 @default.
• W2048446675 cites W2112601022 @default.
• W2048446675 cites W2118148901 @default.
• W2048446675 cites W2120246948 @default.
• W2048446675 cites W2124221188 @default.
• W2048446675 cites W2125389159 @default.
• W2048446675 cites W2154533921 @default.
• W2048446675 cites W2160594014 @default.
• W2048446675 cites W2164099498 @default.
• W2048446675 cites W2170303823 @default.
• W2048446675 cites W2172042588 @default.
• W2048446675 cites W2174167667 @default.
• W2048446675 cites W2316911370 @default.
• W2048446675 cites W2320851674 @default.
• W2048446675 cites W2323478155 @default.
• W2048446675 cites W2324473093 @default.
• W2048446675 cites W2327970682 @default.
• W2048446675 cites W2331067889 @default.
• W2048446675 cites W4296391115 @default.
• W2048446675 doi "https://doi.org/10.1097/01.qai.0000219779.50668.e6" @default.
• W2048446675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16688094" @default.
• W2048446675 hasPublicationYear "2006" @default.
• W2048446675 type Work @default.
• W2048446675 sameAs 2048446675 @default.
• W2048446675 citedByCount "27" @default.
• W2048446675 countsByYear W20484466752012 @default.
• W2048446675 countsByYear W20484466752013 @default.
• W2048446675 countsByYear W20484466752014 @default.
• W2048446675 countsByYear W20484466752015 @default.
• W2048446675 countsByYear W20484466752016 @default.
• W2048446675 countsByYear W20484466752017 @default.
• W2048446675 countsByYear W20484466752018 @default.
• W2048446675 countsByYear W20484466752019 @default.
• W2048446675 countsByYear W20484466752022 @default.
• W2048446675 crossrefType "journal-article" @default.
• W2048446675 hasAuthorship W2048446675A5018068497 @default.
• W2048446675 hasAuthorship W2048446675A5019902771 @default.
• W2048446675 hasAuthorship W2048446675A5031995978 @default.
• W2048446675 hasAuthorship W2048446675A5041046421 @default.
• W2048446675 hasAuthorship W2048446675A5063673979 @default.
• W2048446675 hasAuthorship W2048446675A5066678441 @default.
• W2048446675 hasAuthorship W2048446675A5068183703 @default.
• W2048446675 hasAuthorship W2048446675A5068421356 @default.
• W2048446675 hasAuthorship W2048446675A5069833123 @default.
• W2048446675 hasAuthorship W2048446675A5074256223 @default.
• W2048446675 hasAuthorship W2048446675A5079591035 @default.
• W2048446675 hasAuthorship W2048446675A5079993549 @default.
• W2048446675 hasAuthorship W2048446675A5085944444 @default.
• W2048446675 hasAuthorship W2048446675A5088309165 @default.
• W2048446675 hasBestOaLocation W20484466751 @default.

• next